The project’s focus is on developing a sensor technology platform that can collect accurate health information in real time, thereby creating a more effective process for promoting individualized treatment and a higher quality of life for patients with a degenerative neurological disease that affects more than 10 million people worldwide.
The project is called Musyq (Multimodal motor symptoms quantification platform for individualized Parkinson’s disease treatment) and is managed by Acreo Swedish ICT with contributors in academia, healthcare and business. Collaboration partners include two university hospitals (Uppsala University Hospital and Sahlgrenska University Hospital), two universities (Uppsala University and Dalarna University) and growth companies, Cenvigo AB and Sensidose AB, . The Swedish Parkinson’ Disease Association is also be involved in the project.
New assessment technology
Musyq’s main objective is to develop a new type of assessment equipment for home care purposes that can provide continuous measurement of a patient’s health status in order to improve treatment and quality of life.
The platform will track and measure real-time motor symptoms in a patient’s daily life, providing a more continuous and accurate measurement of a patient’s health status than is available today. This will allow health care providers to more effectively observe changes and take adequate action when symptoms indicate a decline in condition.